Malaysia Targets Asian Bioherbal Innovation Hub Status

KUALA LUMPUR, AUGUST 2026 — Malaysia is positioning itself to become a leading bioherbal innovation hub in Asia as the government seeks to unlock the commercial and scientific potential of the country’s herbal industry.

Health Minister Datuk Seri Dr Dzulkefly Ahmad said the sector could generate between RM30 billion and RM50 billion in economic value over the next 10 years if supported by coordinated public and private investment and clearly defined policy priorities.

The proposal was discussed during the first meeting of the National Herbal Development Council, which is tasked with advancing policies and strategic objectives for Malaysia’s herbal industry.

According to Dzulkefly, future growth should extend beyond the traditional production and sale of herbal products. Malaysia should instead develop a modern ecosystem that combines scientific research, clinical validation, advanced manufacturing and export-oriented commercialisation.

Among the priorities identified are the commercial cultivation of selected medicinal plants, evidence-based herbal medicine and clinical studies designed to verify the safety and effectiveness of herbal compounds.

Artificial intelligence could also play an important role by helping researchers identify valuable phytochemical compounds more efficiently and accelerating the discovery of potential therapeutic applications.

The government also intends to strengthen genomic and metabolomic research involving herbal compounds. These fields could improve understanding of how plant-based substances interact with the human body and support the development of more targeted health products.

Other priorities include stronger intellectual-property protection, international patent registration and the creation of halal herbal products designed for export markets.

Dzulkefly said these efforts should be integrated with biotechnology and precision medicine while being supported by a stronger regulatory pathway aligned with international standards.

Malaysia’s biodiversity is viewed as one of its strongest competitive advantages.

The country is recognised as one of the world’s 17 megadiverse nations, while approximately 1,200 plant species in Peninsular Malaysia have been identified as possessing medicinal value.

Malaysia also ranks 12th globally in the National Biodiversity Index, providing a significant natural foundation for research, product development and sustainable economic growth.

However, the government believes the country’s biological resources must be transformed into commercially viable innovations rather than remaining limited to traditional use.

This will require stronger cooperation among researchers, universities, biotechnology centres, manufacturers, regulatory bodies and investors.

Malaysia’s globally recognised halal-certification system is another advantage that could help local companies enter the rapidly expanding Muslim healthcare and wellness market.

The country’s halal leadership could support the development of herbal medicines, supplements, nutraceutical products and personal-care items that meet religious, safety and quality requirements.

Malaysia also has a well-established scientific ecosystem supported by the Malaysian Herbal Monograph and expertise from agencies such as the Institute for Medical Research and the Forest Research Institute Malaysia.

Local universities, biotechnology centres and research institutions are expected to contribute to clinical research, product standardisation and the development of higher-quality herbal products.

The country’s pharmaceutical and nutraceutical manufacturing capacity could further support the industry’s expansion.

Malaysia already has Good Manufacturing Practice-certified facilities capable of producing products that meet the standards required for international export markets.

This infrastructure could allow locally developed herbal innovations to move more efficiently from research laboratories into commercial production.

Dzulkefly stressed that building a competitive bioherbal industry would require a whole-of-government and nationwide approach.

The initiative is expected to involve SME Corp, the Malaysian Research Accelerator for Technology and Innovation, the Agriculture and Food Security Ministry, the Natural Resources and Environmental Sustainability Ministry, the Health Ministry, universities and industry representatives.

He also called for reduced bureaucracy, faster decision-making and more aggressive policy implementation to ensure promising research and investment opportunities are not delayed.

The long-term objective is to establish Malaysia not merely as a producer of traditional herbs, but as an advanced Asian centre integrating biodiversity, biotechnology, precision medicine and halal excellence.

Achieving that goal could create new research opportunities, support high-value employment, attract investment and expand Malaysia’s presence in the global healthcare, wellness and biotechnology markets.